Lyme Disease and Health Care Costs.

ABSTRACT:

Importance

Lyme disease (LD) is the most common vector-borne illness in the US. Given the increasing prevalence and expanding geographic bounds of LD, in-depth, up-to-date understanding of costs associated with an LD diagnosis, including patient out-of-pocket (OOP) costs, is needed.

Objective

To assess health care costs in a broad US population diagnosed with LD, overall and stratified by localized disease vs disseminated disease.

Design, setting, and participants

This retrospective cohort study identified patients from Optum's deidentified Market Clarity Data (Optum Market Clarity) between December 2, 2014, and January 30, 2023 (study period), with an LD diagnosis between January 1, 2016, and December 31, 2022 (identification period), having at least 14 months of con

SUBMITTER: Yu H 

PROVIDER: S-EPMC12805444 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature